Antibiotic Resistance Markets (Therapeutics): Market Insights and Forecasts by Pathogen and Therapy with Situation Analysis, Executive and Investment Guides 2023 to 2027
Publication date: July 2023
Antimicrobial resistance is creating new kinds of infections and 'superbugs' that are resistant to current antibiotic medicines. New technologies and drugs are under development to capture this growing market. We have identified the 6 key large opportunities in this space and developed market forecasts. We look at the technology landscape giving you plain language understanding of the different ways pathogens and infections can be treated, including an explanation of the key role diagnostics will play. This is a market with a lot of players - there are 100+ biotechnology companies profiled in the report, including summaries of the technologies in use or development.
Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it.
All report datasets are available in Excel format on request with the corporate license.
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional and co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell is a member of The American Association for Clinical Chemistry. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School